[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100389474":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":50,"collaborators":18,"id":52,"slug":18,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":18,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":18,"maxAge":18,"enrollmentInfo":59,"targetDuration":18,"studyType":62,"phases":63,"briefSummary":66,"conditions":67,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ivermectin","EXPERIMENTAL","Ivermectin alone in larger doses",[13],"Drug: Ivermectin",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard treatment","NO_INTERVENTION","Standard of care treatment",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"DRUG","ivermectin",[9],[25],{"name":26,"affiliation":27,"role":28},"sherief Abd-Elsalam, Ass. Prof.","Tanta University - Faculty of Medicine","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[36],{"facility":5,"status":37,"city":38,"state":18,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Tanta","35111","Egypt",{"type":42,"coordinates":43},"Point",[44,45],31.00192,30.78847,{"lat":45,"lon":44},[48],{"name":49,"role":32,"phone":18,"phoneExt":18,"email":18},"Sherief Abd-Elsalam",{"type":28,"investigatorFullName":49,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Ass. Prof. Tropical Medicine","100389474",false,"NCT04351347","The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment","Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment","Inclusion Criteria:\n\n* Patients with covid 19\n\nExclusion Criteria:\n\n* Allergy or side effects to treatment","ALL",{"count":60,"type":61},300,"ESTIMATED","INTERVENTIONAL",[64,65],"PHASE2","PHASE3","Efficacy of Ivermectin in larger doses in COVID-19 treatment",[68],"COVID","2021-03-08",{"date":71,"type":72},"2021-03-10","ACTUAL",{"date":74,"type":72},"2020-06-16",{"date":76,"type":61},"2030-12-01",{"name":5,"class":6},1]